Zhu et al. reported that the expression of a constitutive phosphorylated AKT in prostate cancer cells leads to enhanced NFKB-mediated upregulation of RANKL, PTHrP, and BMP2. This evidence concerns the gene BMP2 and Familial prostate cancer.